Geron Corp (GERN)
$5.58
-0.15 (-2.62%)
| CAPS Rating |
|
|---|---|
| Open | $5.68 |
| Previous Close | $5.73 |
| Daily Range | $5.52 - $5.73 |
| 52-Week Range | $2.48 - $9.24 |
| Market Cap | $511.28M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,044,857 |
| Average Daily Volume | 1,532,000 |
GERN
VS S&P 500 (SPY)
How do you think GERN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GERN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GERN News and Commentary
- Company seeks to test stem cells for blindness – Reuters
- Lab-grown penis helps rabbits mate ... like rabbits – Reuters
- 5 Superball Stocks – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- UPDATE 1-Geron, FDA agree on spinal injury drug trial – Reuters
- Monday's Biggest Stock Stars – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Stock Smackdown: Cramer vs. CAPS – The Motley Fool
- 5 Superball Stocks – The Motley Fool
- A Big Upgrade for Cytori Therapeutics – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Mixed Bag, One-Egg Investing – Blog at The Motley Fool
- 5 Superball Stocks – The Motley Fool
- Beginner's Luck – Blog at The Motley Fool
- Tuesday's Biggest Stock Stars – The Motley Fool
- Stock Smackdown: Cramer vs. CAPS – The Motley Fool
- 4-Star Stocks Poised to Pop: Hansen Medical – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- A Less-Risky Stem Cell Play – The Motley Fool
RSS Headlines
Fool UK
